(Society for Cardiovascular Angiography and Interventions) A new study looked at the effectiveness of novel risk tool to predict 30-day readmission rates in patients undergoing transcatheter aortic valve replacement (TAVR) presented today at SCAI 2018 Scientific Sessions.
from EurekAlert! - Social and Behavioral Science https://ift.tt/2I3uBIF
No comments:
Post a Comment